Trial Profile
Efficacy, tolerability and pharmacodynamics of long-term use of tocilizumab in patients with giant cell arteritis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 Sep 2014
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary) ; Prednisone
- Indications Giant cell arteritis
- Focus Adverse reactions; Pharmacodynamics; Therapeutic Use
- 12 Sep 2014 New trial record